LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2023. The put-call ratio across all filers is 11.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,011,329 | -49.0% | 6,810,428 | +10.4% | 0.00% | 0.0% |
Q2 2023 | $19,624,559 | +5.0% | 6,171,245 | -22.1% | 0.00% | 0.0% |
Q1 2023 | $18,694,155 | -69.2% | 7,921,252 | -54.7% | 0.00% | -50.0% |
Q4 2022 | $60,727,908 | +54.0% | 17,500,838 | +225.3% | 0.00% | 0.0% |
Q3 2022 | $39,434,000 | +133.0% | 5,379,838 | +107.2% | 0.00% | +100.0% |
Q2 2022 | $16,925,000 | +77.2% | 2,595,919 | +37.3% | 0.00% | – |
Q1 2022 | $9,549,000 | +194.4% | 1,890,929 | +351.1% | 0.00% | – |
Q4 2021 | $3,244,000 | -22.8% | 419,184 | +47.7% | 0.00% | – |
Q3 2021 | $4,200,000 | – | 283,802 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,329,235 | $330,147,000 | 32.44% |
Apoletto Ltd | 15,167,757 | $246,324,000 | 32.33% |
Foresite Capital Management IV, LLC | 13,282,181 | $215,703,000 | 29.16% |
Kirkoswald Asset Management LLC | 1,000 | $16,000 | 9.88% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,320,000 | $21,436,800,000 | 3.90% |
HSG Holding Ltd | 2,436,798 | $39,574,000 | 2.76% |
Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $26,761,000 | 2.50% |
Alphabet Inc. | 5,865,125 | $95,250,000 | 1.94% |
Arena Capital Advisors, LLC- CA | 545,137 | $8,853,000 | 0.73% |
SB Management Ltd | 3,500,000 | $56,840,000 | 0.67% |